31
Participants
Start Date
January 16, 2019
Primary Completion Date
October 31, 2022
Study Completion Date
October 31, 2022
Adavosertib
Given PO
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
MedStar Georgetown University Hospital, Washington D.C.
Duke University Medical Center, Durham
University of Florida Health Science Center - Gainesville, Gainesville
University of Kentucky/Markey Cancer Center, Lexington
M D Anderson Cancer Center, Houston
University of Colorado Hospital, Aurora
City of Hope Comprehensive Cancer Center, Duarte
National Cancer Institute (NCI)
NIH